Results 31 to 40 of about 2,645,136 (362)
Combination Antithrombotic Therapies [PDF]
Atherothrombosis is the major pathophysiological process responsible for the occurrence of severe ischemic events in patients with cardiovascular diseases. In the United States, atherothrombosis strongly influenced mortality in 2004: One in 2.8 deaths was due to CVD, 1 in 5 deaths to coronary heart disease, and 1 in 17 deaths to stroke.1 Because ...
Paul A, Gurbel, Udaya S, Tantry
openaire +2 more sources
A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancers. [PDF]
mTOR inhibition has emerged as a promising strategy for head and neck squamous cell carcinomas (HNSCC) treatment. However, most targeted therapies ultimately develop resistance due to the activation of adaptive survival signaling mechanisms limiting the ...
Amornphimoltham, Panomwat +10 more
core +1 more source
Objective Inhibiting preterm labour at extremely early gestations.Design Observational study. Case reports.Setting Perinatal Centre Lund University Hospital, South Sweden.Population Twenty‐five women (13 cases with intact membranes and 12 cases with ruptured) with threatened preterm labour and advanced cervical status before 26 completed weeks of ...
openaire +2 more sources
Combination therapy of hypertension
The article is a short overview of articles related to the prescription of combination antihypertensive therapy. The focus is on the evidence of administration of a fixed combination - lercanidipine plus enalapril, which is characterized by a high ...
O. O. Bolshakova
doaj +1 more source
Combination Therapy of Sorafenib and Transarterial Chemoembolization in Management of Hepatoma [PDF]
Incidence of hepatocellular carcinoma (HCC) continues to increase in developing countries and rank 5th in male and 7th in female. Main cause being reported is chronic hepatitis B in Asian region. Treatment of choice for HCC is liver resection, however it
Gani, R. A. (Rino) +3 more
core +1 more source
Combination therapy for hypertension
No abstract available.
J.A. Ker
doaj +1 more source
MTOR cross-talk in cancer and potential for combination therapy [PDF]
The mammalian Target of Rapamycin (mTOR) pathway plays an essential role in sensing and integrating a variety of exogenous cues to regulate cellular growth and metabolism, in both physiological and pathological conditions.
Bazzichetto, C. +7 more
core +3 more sources
Combination therapy in hypertension
Hypertension is one of the most important risk factors for death, heart failure, ischaemic heart disease, stroke and chronic kidney disease. Treatment of hypertension to particularly to goal blood pressure (BP) prevents these complications.
Brian Rayner
doaj +1 more source
Efficacy of Elaborated Semantic Features Analysis in Aphasia: a quasi-randomised controlled trial [PDF]
Background: Word finding difficulty is one of the most common features of aphasia. Semantic Features Analysis (SFA) directly aims to improve word finding in people with aphasia.
Elman R. +13 more
core +1 more source
Combination Therapy in Hypertension
Editor’s Note: The American Society of Hypertension is publishing a series of Position Papers in their official journals throughout the 2008–2011 years. The following Position Paper originally appeared: JASH. 2010;4:42–50.The goal of antihypertensive therapy is to abolish the risks associated with blood pressure (BP) elevation without adversely ...
Alan H, Gradman +8 more
openaire +5 more sources

